BridgeBio Pharma Inc (BBIO) Ownership

24.70 ↓0.25 (-1.02%)
As of April 19, 2024, 12:51pm EST.

Institutional Ownership

Kohlberg Kravis Roberts & Co LP is the biggest individual institutional holder of BridgeBio Pharma Inc (BBIO), owning a total of 31.1 million shares. Combined, the top 38 institutional holders of BBIO own 84.79% of the company with a total of 153.1 million shares.

In the latest ownership report on December 31st 2023, the top 38 institutional holders increased their combined ownership of BBIO by 9.3 million shares. 10 institutions bought 10,846,507 total additional shares and increased their ownership by an average of 74.58%. However 4 institutions sold 1,520,617 total shares and decreased their ownership by an average of 9.14%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of BridgeBio Pharma increased by a net total of 9,325,890 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Kohlberg Kravis Roberts & Co LP16.840%0.000%31,060,97102023-12-31
Viking Global Investors LP13.619%0.000%25,120,99102023-12-31
Vanguard Group Inc6.940%13.518%12,800,2941,524,3132023-12-31
BlackRock Inc5.507%9.804%10,156,773906,8302023-12-31
Goldman Sachs Group Inc3.542%358.425%6,533,2705,108,1132023-12-31
Aisling Capital Management LP3.290%0.000%6,068,12502023-12-31
State Street Corporation2.758%0.922%5,086,89946,4852023-12-31
Cormorant Asset Management, LLC1.813%-28.275%3,344,179-1,318,3512023-12-31
Lord, Abbett & Co LLC1.680%289.990%3,098,0822,303,6812023-12-31
Pictet Asset Manangement SA1.500%0.991%2,767,18527,1632023-12-31
Geode Capital Management, LLC1.472%8.083%2,714,168202,9882023-12-31
AllianceBernstein L.P.1.387%-5.844%2,557,416-158,7242023-12-31
FMR Inc1.309%-0.543%2,414,341-13,1812023-12-31
SC US (TTGP), LTD.1.009%0.000%1,860,36402023-12-31
Perceptive Advisors LLC0.948%0.000%1,748,93302023-12-31
Morgan Stanley - Brokerage Accounts0.900%14.621%1,659,782211,7222023-12-31
Citigroup Inc0.844%-1.912%1,557,231-30,3612023-12-31
Wellington Management Company LLP0.811%5.323%1,495,11475,5642023-12-31
T. Rowe Price Investment Management,Inc.0.778%44.158%1,435,280439,6482023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Kohlberg Kravis Roberts & Co LP16.840%0.000%31,060,97102023-12-31
Viking Global Investors LP13.619%0.000%25,120,99102023-12-31
Vanguard Group Inc6.940%13.518%12,800,2941,524,3132023-12-31
BlackRock Inc5.507%9.804%10,156,773906,8302023-12-31
Goldman Sachs Group Inc3.542%358.425%6,533,2705,108,1132023-12-31
Aisling Capital Management LP3.290%0.000%6,068,12502023-12-31
LAURION CAPITAL MANAGEMENT LP3.064%18.986%5,651,039901,6962023-09-30
State Street Corporation2.758%0.922%5,086,89946,4852023-12-31
Cormorant Asset Management, LLC1.813%-28.275%3,344,179-1,318,3512023-12-31
Lord, Abbett & Co LLC1.680%289.990%3,098,0822,303,6812023-12-31
Citadel Advisors Llc1.793%58.872%2,877,1881,066,1762022-12-31
Hillhouse Capital Advisors, Ltd.1.600%-7.039%2,782,750-210,6972023-09-30
Pictet Asset Manangement SA1.500%0.991%2,767,18527,1632023-12-31
Geode Capital Management, LLC1.472%8.083%2,714,168202,9882023-12-31
AllianceBernstein L.P.1.387%-5.844%2,557,416-158,7242023-12-31
FMR Inc1.309%-0.543%2,414,341-13,1812023-12-31
SC US (TTGP), LTD.1.009%0.000%1,860,36402023-12-31
Perceptive Advisors LLC0.948%0.000%1,748,93302023-12-31
Morgan Stanley - Brokerage Accounts0.900%14.621%1,659,782211,7222023-12-31
Citigroup Inc0.844%-1.912%1,557,231-30,3612023-12-31
Wellington Management Company LLP0.811%5.323%1,495,11475,5642023-12-31
T. Rowe Price Investment Management,Inc.0.778%44.158%1,435,280439,6482023-12-31
Bank of America Corp0.840%61.390%1,365,057519,2452023-03-31
D. E. Shaw & Co LP0.771%-17.866%1,341,243-291,7432023-09-30
Jacobs Levy Equity Management, Inc.0.800%6.992%1,283,99083,9122022-12-31
Two Sigma Investments LLC0.734%72.488%1,277,084536,6932023-09-30
Octagon Capital Advisors LP0.750%-8.890%1,219,200-118,9602023-06-30
Barclays PLC0.749%3,982.770%1,201,8851,172,4472022-12-31
Millennium Management LLC0.770%93.616%1,165,308563,4412022-09-30
Northern Trust Corp0.695%17.957%1,129,272171,9152023-06-30
Marshall Wace Asset Management Ltd0.668%0.000%1,084,5951,084,5952023-03-31
Ensign Peak Advisors Inc0.665%0.000%1,080,25902023-06-30
Great Point Partners LLC0.697%0.000%1,050,0001,050,0002022-09-30
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.650%65.287%1,042,486411,7752023-03-31
PRIMECAP Management Company0.694%-1.434%1,037,730-15,1002022-09-30
Renaissance Technologies Corp0.680%-24.643%1,029,946-336,8002022-12-31
Avidity Partners Management LP0.623%0.000%1,000,0001,000,0002023-03-31
American International Group Inc0.602%-63.843%977,812-1,726,5622023-06-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of BridgeBio Pharma Inc (BBIO), owning a total of 4.1 million shares. Combined, the top 40 mutual fund holders of BBIO own 25.38% of the company with a total of 45.4 million shares.

In the latest ownership report on March 28th 2024, the top 40 fund holders increased their combined ownership of BBIO by 39 thousand shares. 2 funds bought 42,113 total additional shares and increased their ownership by an average of 0.79%. However 2 funds sold 3,385 total shares and decreased their ownership by an average of 0.19%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding BridgeBio Pharma increased by a net total of 38,728 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Russell 2000 ETF1.548%0.312%2,856,1368,8732024-03-28
SPDR® S&P Biotech ETF1.429%1.277%2,636,42033,2402024-03-28
iShares Biotechnology ETF0.527%-0.263%972,514-2,5652024-03-28
iShares Russell 2000 Growth ETF0.382%-0.116%704,794-8202024-03-28

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.238%-0.257%4,128,409-10,6532024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr1.987%9.920%3,457,388312,0182023-03-31
Vanguard Small Cap Index1.823%0.937%3,362,70831,2142024-02-29
iShares Russell 2000 ETF1.548%0.312%2,856,1368,8732024-03-28
SPDR® S&P Biotech ETF1.429%1.277%2,636,42033,2402024-03-28
Vanguard Small Cap Value Index Inv1.080%0.427%1,991,7948,4592024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.034%-0.071%1,906,734-1,3542024-02-29
Vanguard Extended Market Index Investor1.006%0.412%1,634,0326,7052023-08-31
Lord Abbett & Co. Growth Equity- SA0.779%0.000%1,436,2061,436,2062023-12-31
Fidelity® Select Biotechnology0.722%0.000%1,255,34602023-11-30
Lord Abbett Growth Leaders I0.639%-17.543%1,178,856-250,8102024-02-29
Fidelity Small Cap Index0.627%1.662%1,157,05118,9202024-01-31
Lord Abbett Developing Growth A0.616%0.000%1,135,53702024-02-29
Fidelity® Small Cap Index0.634%2.775%1,102,36129,7692023-10-31
Pictet-Biotech P USD0.556%-0.130%1,025,604-1,3382023-12-31
MEDICAL BioHealth EUR Acc0.539%0.000%994,38002023-11-30
iShares Biotechnology ETF0.527%-0.263%972,514-2,5652024-03-28
American Funds SMALLCAP World A0.524%0.000%965,65302023-12-31
Fidelity Select Biotechnology0.513%-16.057%946,496-181,0502024-02-29
AB Small Cap Growth A0.417%-2.487%768,831-19,6102024-02-29
Pictet-Global Megatrend Sel I USD0.412%13.732%760,67591,8442023-12-31
Fidelity Extended Market Index0.393%0.556%724,1624,0012024-02-29
Eventide Healthcare & Life Sciences I0.389%0.000%716,92702023-12-31
iShares Russell 2000 Growth ETF0.382%-0.116%704,794-8202024-03-28
State St Russell Sm/Mid Cp® Indx NL Cl C0.396%3.158%695,84821,3002024-02-29
Fidelity® Extended Market Index0.372%1.067%646,7576,8282023-11-30
Schwab US Small-Cap ETF™0.336%0.000%584,33202024-01-31
Direxion Daily S&P Biotech Bull 3X ETF0.339%3.470%551,14818,4832023-08-31
Pictet Biopharmaceutical Mother0.313%-25.269%544,500-184,1112023-10-13
Vanguard Strategic Equity Inv0.333%7.232%533,63635,9882023-03-31
AB Discovery Growth A0.290%26.036%504,422104,2002023-09-30
UBS (Lux) EF Biotech (USD) P-acc0.283%-0.937%491,948-4,6552023-09-30
State St Russell Sm Cap® Indx NL Cl C0.264%0.000%428,82602023-08-31
iShares Russell 2000 Value ETF0.254%0.562%407,4822,2772023-06-21
BlackRock Advantage Small Cap Core Instl0.253%-12.250%405,527-56,6142023-02-28
Vanguard Explorer Inv0.237%23.712%380,59272,9492023-03-31
PRIMECAP Odyssey Aggressive Growth0.230%1.622%369,6005,9002023-03-31
USAA Science & Technology0.243%64.875%362,481142,6292022-09-30
Vanguard Capital Opportunity Inv0.213%0.000%340,90002023-01-31
CREF Stock R10.208%-0.973%338,066-3,3202023-05-31

Discussions

Please log in or register to share your thoughts.

BretJohns

$BBIO recovery hasn’t even started yet.. imo

0 Like Report
AppleBigTech

$BBIO Come on.. Let it fall.. buy later bulls

0 Like Report
glaglewd

$BBIO my hands are made out of diamonds

0 Like Report